FEB 02, 2016 3:51 PM PST

Inflammation Can Cause Fatigue and Depression

WRITTEN BY: Kara Marker
Although the body needs inflammation to fight off infections, this product of the innate immune system has been linked to many health problems when inflammatory molecules are released in excess. The newest study has connected inflammation as a side effect from a hepatitis C treatment to structural changes in the striatum, the reward center of the brain.
 
A transverse section of the striatum


Inflammation is known to increase the risk of depression, a relationship developed and exacerbated by certain behavior changes:
  • Fatigue
  • Difficulty focusing
  • Lack of motivation
  • Reduced experience of pleasure
In a study of 23 patients with hepatitis C, researchers observed how each participant reacted to a treatment of interferon-alpha over several weeks. Interferon-alpha has been used in a clinical setting for over 16 years, successfully fighting infections by priming the immune response with cytokine regulation (Journal of Leukocyte Biology). The study was published in Biological Psychiatry.
 
Four hours after receiving the interferon-alpha treatment, the researchers could already see “microstructural changes” in the striatum, as compared to the striatum before treatment, using magnetization transfer imaging.
 
In the weeks following treatment, participants also reported fatigue and depression, especially between weeks 4 and 12. However, the impact of interferon-alpha appeared to be twofold, with both protective changes in structure and changes that increased the risk of fatigue visible in the striatum. No visible changes were directly linked to depression, though.
 
“The heterogeneous striatal response may suggest that fatigue and mood are supported by different microcircuits within the striatum,” explained Dr. John Krystal, Editor of Biological Psychiatry, in response to the dual change. Scientists might soon be looking for structural changes in places in the brain other than the striatum to link back to the reports of depression.
 
 
Source: Elsevier
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 28, 2020
Immunology
Neonatal Origins of Chronic Inflammatory Disease
JUL 28, 2020
Neonatal Origins of Chronic Inflammatory Disease
From birth, our genes write the story of our lives. For many people who develop chronic immune and inflammatory diseases ...
AUG 11, 2020
Immunology
Study Reveals the Two Sides of an Immune Molecule
AUG 11, 2020
Study Reveals the Two Sides of an Immune Molecule
Scientists have discovered a key protein that regulates the immune system to fight off infections. Fascinatingly, the pr ...
AUG 19, 2020
Cell & Molecular Biology
Mild COVID-19 Cases Induce an Immune Cell Response
AUG 19, 2020
Mild COVID-19 Cases Induce an Immune Cell Response
As the pandemic virus, SARS-CoV-2 continues to cause tens of thousands of new cases of COVID-19 every day in the United ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
Loading Comments...